The potential regulatory relationship between hsa_circ_0000973 and MBOAT2 in hypertriglyceridemia with abnormal glucose metabolism
Human Molecular Genetics · 28.07.2026 · 35 (16)
DOI: 10.1093/hmg/ddag074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 06.08.2026. Verfasst von Fengdan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, No. 1163 Xinmin Street, Chaoyang District, Changchun 130021,…. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Glucose, RNA, Circular. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypertriglyceridemia (HTG) frequently occurs in population with abnormal glucose metabolism (AGM), exacerbating risk. In our preliminary researches, we have screened hsa_circ_0000973 and MBOAT2 as the possible regulatory elements of HTG in AGM patients. This study enrolled 142 AGM subjects (71 with HTG, 71 with normal triglycerides) to investigate the role and mechanism of the hsa_circ_0000973 and MBOAT2 in AGM-associated HTG. Expression levels of hsa_circ_0000973 and MBOAT2 were measured by RT-qPCR. Diagnostic performance was evaluated via ROC analysis. Functional validation was performed in an insulin-resistant (IR) HepG2 cell model following knockdown of hsa_circ_0000973 or MBOAT2 using siRNA. Cellular triglyceride (TG) content, glucose uptake, proliferation, apoptosis, and expression of lipid metabolism transcription factors (SREBP-1c, PPARα, PPARγ) were assessed. In the AGM population, expression of both hsa_circ_0000973 and MBOAT2 was significantly downregulated in the HTG group and negatively correlated with serum TG levels (P <0 .01). hsa_circ_0000973 exhibited high diagnostic accuracy for HTG in the AGM population (AUC = 0.95). In HepG2-IR cells, knockdown of hsa_circ_0000973 decreased MBOAT2 expression, increased cellular TG accumulation and residual glucose, inhibited proliferation, and promoted apoptosis. Similar phenotypes were observed upon MBOAT2 knockdown. Both knockdowns upregulated SREBP-1c and downregulated PPARα and PPARγ. This study identified that hsa_circ_0000973 may serve as a candidate biomarker for identifying HTG specifically within the AGM population. Our in vitro experiments further suggested that, in the setting of AGM, hsa_circ_0000973 may jointly regulated TG metabolism alongside MBOAT2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, No. 1163 Xinmin Street, Chaoyang District, Changchun 130021, P. R. China.
- Institute of Chronic Non-Communicable Disease Control and Prevention, Beijing Center for Disease Prevention and Control, No. 16 Hepingli Middle Street, Dongcheng District, Beijing 100013, P. R. China.
- School of Nursing, Jilin University, No. 965 Xinjiang Street, Chaoyang District, Changchun 130021, P. R. China.
- Department of Health Examination Center, The First Hospital of Jilin University, No. 1 Xinmin Street, Chaoyang District, Changchun 130021, P. R. China.
ORCID-Profile: Bo Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, F., Yang, Y., Li, X., Xu, Y., Yan, S., Li, B., & Zhao, D. (2026). The potential regulatory relationship between hsa_circ_0000973 and MBOAT2 in hypertriglyceridemia with abnormal glucose metabolism. Human Molecular Genetics, 35(16). https://doi.org/10.1093/hmg/ddag074
Vancouver
Wang F, Yang Y, Li X, Xu Y, Yan S, Li B, et al. The potential regulatory relationship between hsa_circ_0000973 and MBOAT2 in hypertriglyceridemia with abnormal glucose metabolism. Human Molecular Genetics. 2026;35(16). doi:10.1093/hmg/ddag074
BibTeX
@article{Wang2026,
author = {Wang, Fengdan and Yang, Yixue and Li, Xiaotong and Xu, Yang and Yan, Shoumeng and Li, Bo and Zhao, Di},
title = {The potential regulatory relationship between hsa_circ_0000973 and MBOAT2 in hypertriglyceridemia with abnormal glucose metabolism},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {16},
doi = {10.1093/hmg/ddag074}
}
EUVIMED